End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.34 CNY | -0.64% | -2.06% | +1.48% |
May. 27 | ZBD Pharma Gets China Approval for Gastric Acid Inhibiting Tablets | MT |
May. 07 | China Grants Drug Registration Approval for ZBD Pharma's Anti-Epilepsy Injectable | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.48% | 1.6B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 603567 Stock
- News Heilongjiang ZBD Pharmaceutical Co., Ltd.
- Heilongjiang ZBD’s Anti-Pulmonary Fibrosis Drug Gets U.S. Patent